Niyazi Emre Turgut

Niyazi Emre Turgut

Auto-generated profile, based on publicly available information

Niyazi Emre Turgut

İstanbul Gelişim University Faculty of Health Sciences, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
ETEmre Niyazi Turgut
Emre Niyazi Turgut
FBFazilet Kübra Boynukalın
Fazilet Kübra Boynukalın
MGMeral Gültomruk
Meral Gültomruk
ZYZalihe Yarkıner
Zalihe Yarkıner
MBMustafa Bahçeci
Mustafa Bahçeci
Cryopreservation of embryos for future transfer attempts has noticeably increased in the last decade, especially due to the technological developments in in vitro fertlization (IVF) laboratories. In parallel, different progesterone (P) replacement regimens preceding artificially prepared frozen embryo transfer (AC-FET) attempts, especially with respect to the route of application and dosing scheme, have been widely argued so far. We aimed to provide more information about the efficacy profile of novel subcutaneous aqueous progesterone (SP) in AC-FET cycles. This retrospective, single-centre cohort study included a total of 507 AC-FET cycles performed between June 2018 and April 2020. Three hundred forty-nine (68.8%) patients received 50 mg of intramuscular progesterone as once daily, 158 (31.2%) patients received 25 mg of SP as twice daily. Only, the first and single blastocyst transfers from the same cohort were accepted. The inclusion criteria were as follows: females aged <37 years, body mass index ≥18 kg/m2 and ≤35 kg/m2, sperm concentration ≥5x106/mL. Pre-implantation genetic testing cycles were not included. The primary outcome was the live birth rate (LBR). The number of previous IVF attempts, type of infertility, peak estradiol (E2) levels, the total number of retrieved oocytes, mature oocytes, and the number of 2PN was significantly different between the groups. Positive pregnancy (p=0.474) and clinical pregnancy rates (p=0.979), LBR (p=0.404), and missed abortion rates (p=0.144) were comparable between the groups. The total number of oocytes [adjusted odds ratios (AOR)=1.024, 95% confidence interval (CI): 1.002-1.047; p=0.03)], endometrial thickness (AOR=1.121, 95% CI: 1.003-1.253; p=0.044), and cryopreservation day 5/6 (AOR=0.421, 95% CI: 0.226-0.788; p=0.007) achieved statistical significance following binary logistic regression analysis. However, P administration type did not achieve statistical significance (p=0.731). As a novel option, SP has comparable efficacy in pregnancy outcomes and may be accepted as an alternative for luteal phase support in AC-FET cycles.

26 September 2012 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ETEmre Niyazi Turgut
Emre Niyazi Turgut
ECEbru Celik
Ebru Celik
SCSerdar Celik
Serdar Celik
DADeniz Cemgil Arikan
Deniz Cemgil Arikan
HAHuseyin Altuntas
Huseyin Altuntas
RDRamazan Dansuk
Ramazan Dansuk

12 September 2020 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ETEmre Niyazi Turgut
Emre Niyazi Turgut
SESelen Ecemis
Selen Ecemis
KBKubra Fazilet Boynukalin
Kubra Fazilet Boynukalin
MGMeral Gultomruk
Meral Gultomruk
ZYZalihe Yarkiner
Zalihe Yarkiner
MBMustafa Bahceci
Mustafa Bahceci

19 July 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
NTNiyazi Emre Turgut
Niyazi Emre Turgut
FBFazilet Kubra Boynukalin
Fazilet Kubra Boynukalin
MGMeral Gultomruk
Meral Gultomruk
ZYZalihe Yarkiner
Zalihe Yarkiner
RARemzi Abali
Remzi Abali
MBMustafa Bahceci
Mustafa Bahceci

31 July 2010 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
TSTayfun Sahinkanat
Tayfun Sahinkanat
DADeniz Cemgil Arıkan
Deniz Cemgil Arıkan
ETEmre Turgut
Emre Turgut
COCuneyd Ozkurkcugil
Cuneyd Ozkurkcugil
HYHasan Yılmaz
Hasan Yılmaz
HEHasan Ekerbicer
Hasan Ekerbicer

2 July 2020 in Gynecological Endocrinology
Verified
Journal Article
Closed access
FBFazilet Kubra Boynukalin
Fazilet Kubra Boynukalin
ZYZalihe Yarkiner
Zalihe Yarkiner
MGMeral Gultomruk
Meral Gultomruk
NTNiyazi Emre Turgut
Niyazi Emre Turgut
SESelen Ecemis
Selen Ecemis
MBMustafa Bahceci
Mustafa Bahceci
Aim: To evaluate the effect of trigger day progesterone (P) levels on live birth in freeze-all cycles. Material and methods: Retrospective analysis of 1034 freeze-all female patients aged <38 years with single blastocyst transfers. Patients with (n = 268) or without (n = 766) preimplantation genetic test for aneuploidy (PGT-A) arm were further categorized into three subgroups based on trigger day P levels; low (<0.80 ng/ml), medium (0.8–1.49 ng/ml), and high (≥1.50 ng/ml). Results: Estradiol (E2) levels on trigger day, the number of oocytes retrieved and the number of mature oocytes increased significantly with increasing serum p values in cycles without and with PGT-A arms. Significant correlation was found between E2 levels on trigger day and serum P levels and between the number of total oocytes retrieved and serum P levels Live birth rates were similar in the three subgroups in without PGT-A arm (51%, 52.6%, and 51.5%, respectively; p = .922) and with PGT-A arm (55.1%, 55.1%, and 62.5%, respectively; p = .730). Multivariate regression analysis revealed that trigger day P levels were not significant for live birth. Conclusion: The proposal that trigger day progesterone elevation (PE) exerts a detrimental effect on oocyte and embryo competence has no clinical validity. Keywords: Freeze-all; IVF/ICSI; trigger day progesterone